Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) EBT Margin (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed EBT Margin for 2 consecutive years, with 4596.72% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1222191.0% to 4596.72% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13543.04% through Dec 2025, up 1158150.0% year-over-year, with the annual reading at 41176.09% for FY2025, N/A changed from the prior year.
  • EBT Margin for Q4 2025 was 4596.72% at Jupiter Neurosciences, down from 191788.26% in the prior quarter.
  • The five-year high for EBT Margin was 198499.12% in Q2 2025, with the low at 7625.2% in Q4 2024.